VERU INC. Cash and Cash Equivalents
VERU INC. (VERU) had Cash and Cash Equivalents of $23.88 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-10
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $23.88M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $27.60M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $32.99M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $15.79M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $23.88M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $27.60M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $32.99M 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $15.79M 10-Q · filed 2026-08-10 | |
| 2025-06-30 | $15.01M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $20.02M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $26.61M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $24.92M 10-K · filed 2025-12-17 | |
| 2024-06-30 | $29.15M 10-Q · filed 2024-08-08 | |
| 2023-09-30 | $9.63M 10-K · filed 2024-12-16 | |
| 2015-12-31 | $3.67M 10-Q · filed 2016-02-02 | |
| 2015-09-30 | $4.11M 10-Q · filed 2016-02-02 | |
| 2015-06-30 | $2.62M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $2.93M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $4.57M 10-Q · filed 2016-02-02 | |
| 2014-09-30 | $5.80M 10-Q · filed 2016-02-02 | |
| 2014-06-30 | $4.14M 10-Q · filed 2015-07-30 | |
| 2014-03-31 | $5.94M 10-Q · filed 2015-04-30 | |
| 2013-12-31 | $7.99M 10-Q · filed 2015-02-03 | |
| 2013-09-30 | $8.92M 10-K · filed 2015-12-02 | |
| 2013-06-30 | $11.93M 10-Q · filed 2014-07-31 | $11.88M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $6.20M 10-Q · filed 2014-05-01 | $6.15M 10-Q · filed 2013-05-02 |
| 2012-12-31 | $4.33M 10-Q · filed 2014-02-03 | $4.28M 10-Q · filed 2013-01-30 |
| 2012-09-30 | $5.30M 10-K · filed 2015-12-02 | $5.29M 10-K · filed 2012-12-04 |
| 2012-06-30 | $8.29M 10-Q · filed 2013-08-01 | |
| 2012-03-31 | $6.27M 10-Q · filed 2013-05-02 | |
| 2011-12-31 | $4.66M 10-Q · filed 2013-01-30 | |
| 2011-09-30 | $4.25M 10-K · filed 2014-12-02 | $4.25M 10-K · filed 2011-12-02 |
| 2011-06-30 | $3.28M 10-Q · filed 2012-07-31 | |
| 2011-03-31 | $2.61M 10-Q · filed 2012-05-01 | |
| 2010-12-31 | $3.58M 10-Q · filed 2012-01-31 | |
| 2010-09-30 | $2.92M 10-K · filed 2013-12-03 | $2.92M 10-Q · filed 2011-08-05 |
| 2010-06-30 | $3.82M 10-Q · filed 2011-08-05 | |
| 2009-09-30 | $2.81M 10-K · filed 2012-12-04 | |
| 2008-09-30 | $1.92M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |